MCID: MLG074
MIFTS: 40

Malignant Mesenchymoma

Categories: Cancer diseases, Nephrological diseases, Rare diseases

Aliases & Classifications for Malignant Mesenchymoma

MalaCards integrated aliases for Malignant Mesenchymoma:

Name: Malignant Mesenchymoma 12 20 15
Malignant Mesenchymal Tumor 20 44 70
Rat Malignant Renal Mesenchymal Tumor 70
Mesenchymoma, Malignant 12
Sarcoma 70

Classifications:



External Ids:

Disease Ontology 12 DOID:5758
MeSH 44 C535700
NCIt 50 C4268
SNOMED-CT 67 89623007
UMLS 70 C0334492 C1261473 C1882762

Summaries for Malignant Mesenchymoma

MalaCards based summary : Malignant Mesenchymoma, also known as malignant mesenchymal tumor, is related to gallbladder sarcoma and mesenchymal chondrosarcoma. An important gene associated with Malignant Mesenchymoma is MB (Myoglobin), and among its related pathways/superpathways is Mesenchymal Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Bleomycin and Efavirenz have been mentioned in the context of this disorder. Affiliated tissues include bone, uterus and t cells, and related phenotype is muscle.

Related Diseases for Malignant Mesenchymoma

Diseases in the Malignant Mesenchymoma family:

Adult Malignant Mesenchymoma

Diseases related to Malignant Mesenchymoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 242)
# Related Disease Score Top Affiliating Genes
1 gallbladder sarcoma 32.0 MYOG MYOD1 DES
2 mesenchymal chondrosarcoma 30.3 MYOG MYOD1 DES
3 liposarcoma 30.3 MYOG MDM2 MB DES CD34
4 myxosarcoma 30.1 MB CALD1
5 leiomyosarcoma 30.1 SERPINA3 MYOG MDM2 MB DES
6 fibrous histiocytoma 30.1 SERPINA3 DES CD34
7 skin sarcoma 30.0 CD34 CALD1
8 rhabdomyosarcoma 29.8 SSX2 MYOG MYOD1 MDM2 MB DES
9 extraosseous osteosarcoma 29.7 MDM2 CD34 CALD1
10 pleomorphic lipoma 29.6 SERPINA3 MDM2 CD34
11 liposarcoma of bone 29.6 MYOG MDM2 CD34
12 mesenchymal cell neoplasm 29.5 SSX2 SERPINA3 MYOG CD34 CALD1
13 pleomorphic liposarcoma 29.2 SSX2 SERPINA3 MDM2 DES CALD1
14 embryonal sarcoma 29.1 SERPINA3 MYOG MYOD1 MDM2 DES
15 malignant fibrous histiocytoma 29.0 SERPINA3 MYOG MYOD1 MDM2 MB DES
16 lipomatosis, multiple 29.0 SERPINA3 MDM2 DES CD34 CALD1
17 spindle cell sarcoma 28.9 SSX2 SERPINA3 MYOG MDM2 DES CD34
18 retroperitoneal sarcoma 28.9 SSX2 MYOG MDM2 CD34 CALD1
19 well-differentiated liposarcoma 28.9 SSX2 SERPINA3 MYOG MDM2 CD34 CALD1
20 dedifferentiated liposarcoma 28.2 SSX2 SERPINA3 MYOG MDM2 MB DES
21 muscle cancer 28.1 SSX2 SERPINA3 MYOG MYOD1 MDM2 MB
22 sarcoma of cervix uteri 11.3
23 childhood malignant mesenchymoma 11.3
24 adult malignant mesenchymoma 11.3
25 osteogenic sarcoma 10.6
26 chondrosarcoma 10.6
27 fibrosarcoma 10.4
28 rare tumor 10.4
29 giant cell myocarditis 10.3 MB DES
30 congenital epulis 10.3 SERPINA3 DES
31 epulis 10.3 SERPINA3 DES
32 malignant granular cell myoblastoma 10.3 SERPINA3 MB
33 orbit embryonal rhabdomyosarcoma 10.3 MYOG MB
34 granular cell tumor 10.3 SERPINA3 DES
35 scrotum neoplasm 10.3 SERPINA3 MYOG
36 syringocystadenoma papilliferum 10.3 SERPINA3 DES
37 pineal region teratoma 10.3 MYOG MYOD1
38 ectomesenchymoma 10.3 MYOG DES
39 prostate rhabdomyosarcoma 10.3 MYOG MYOD1
40 malignant glandular tumor of peripheral nerve sheath 10.3 SSX2 MYOG
41 central nervous system mesenchymal non-meningothelial tumor 10.3 MYOG MYOD1
42 non-langerhans-cell histiocytosis 10.3 SERPINA3 DES
43 orbit rhabdomyosarcoma 10.2 MYOG MB
44 hobnail hemangioma 10.2 MYOG CD34
45 prostate sarcoma 10.2 MYOG CD34
46 extraosseous ewing sarcoma 10.2 MYOG MYOD1
47 leiomyoma 10.2
48 soft tissue sarcoma 10.2
49 biphasic synovial sarcoma 10.2 SSX2 DES
50 kidney hemangiopericytoma 10.2 SSX2 CD34

Graphical network of the top 20 diseases related to Malignant Mesenchymoma:



Diseases related to Malignant Mesenchymoma

Symptoms & Phenotypes for Malignant Mesenchymoma

MGI Mouse Phenotypes related to Malignant Mesenchymoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 muscle MP:0005369 9.1 DES MB MDM2 MYOD1 MYOG SMTN

Drugs & Therapeutics for Malignant Mesenchymoma

Drugs for Malignant Mesenchymoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 506)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bleomycin Approved, Investigational Phase 4 11056-06-7 5360373
2
Efavirenz Approved, Investigational Phase 4 154598-52-4 64139
3
Emtricitabine Approved, Investigational Phase 4 143491-57-0 60877
4
Lopinavir Approved Phase 4 192725-17-0 92727
5
Nevirapine Approved Phase 4 129618-40-2 4463
6
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825
7
Stavudine Approved, Investigational Phase 4 3056-17-5 18283
8
Sirolimus Approved, Investigational Phase 4 53123-88-9 6436030 5284616
9
Clotrimazole Approved, Vet_approved Phase 4 23593-75-1 2812
10
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
11
tannic acid Approved Phase 4 1401-55-4
12
Benzocaine Approved, Investigational Phase 4 1994-09-7, 94-09-7 2337
13
Tranexamic Acid Approved Phase 4 1197-18-8 5526
14
Heparin Approved, Investigational Phase 4 9005-49-6 772 9812414
15
Dalteparin Approved Phase 4 9005-49-6
16
Tinzaparin Approved Phase 4 9041-08-1, 9005-49-6 25244225
17
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
18
Enoxaparin Approved Phase 4 9005-49-6 772
19
Tenofovir Experimental, Investigational Phase 4 147127-20-6 464205
20 Reverse Transcriptase Inhibitors Phase 4
21 Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Phase 4
22 Antifungal Agents Phase 4
23 Coagulants Phase 4
24 Antifibrinolytic Agents Phase 4
25 Hemostatics Phase 4
26 Anticoagulants Phase 4
27 Fibrinolytic Agents Phase 4
28 Heparin, Low-Molecular-Weight Phase 4
29 calcium heparin Phase 4
30 Antipyretics Phase 4
31 Platelet Aggregation Inhibitors Phase 4
32
Dactinomycin Approved, Investigational Phase 3 50-76-0 2019 457193
33
Zidovudine Approved Phase 3 30516-87-1 35370
34
Ritonavir Approved, Investigational Phase 2, Phase 3 155213-67-5 392622
35
Treosulfan Approved, Investigational Phase 3 299-75-2 9296
36
Abacavir Approved, Investigational Phase 2, Phase 3 136470-78-5 441300 65140
37
Panitumumab Approved, Investigational Phase 3 339177-26-3 50070211
38
Palbociclib Approved, Investigational Phase 3 571190-30-2 5005498 5330286 11431660
39
Olaparib Approved Phase 3 763113-22-0 23725625
40
Trametinib Approved Phase 3 871700-17-3 11707110
41
Ceritinib Approved Phase 3 1032900-25-6
42
Dabrafenib Approved, Investigational Phase 3 1195765-45-7 44462760 44516822
43
Lapatinib Approved, Investigational Phase 3 231277-92-2, 388082-78-8 208908 9941095
44
Sorafenib Approved, Investigational Phase 3 284461-73-0 216239 406563
45
Ifosfamide Approved Phase 3 3778-73-2 3690
46
Paclitaxel Approved, Vet_approved Phase 3 33069-62-4 36314
47
Levoleucovorin Approved, Investigational Phase 3 68538-85-2 149436
48
Carboplatin Approved Phase 3 41575-94-4 10339178 498142 38904
49
Olaratumab Approved, Investigational Phase 3 1024603-93-7
50
Bortezomib Approved, Investigational Phase 3 179324-69-7 93860 387447

Interventional clinical trials:

(show top 50) (show all 1415)
# Name Status NCT ID Phase Drugs
1 EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children Unknown status NCT00339118 Phase 4 doxorubicin, cytoxan
2 A Randomized Comparison of Protease Inhibitor-based Versus Non-nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy for Initial Treatment of Individuals With AIDS-related Kaposi's Sarcoma in Sub-Saharan Africa Completed NCT00444379 Phase 4 Lopinavir/ritonavir plus Emtricitabine/Tenofovir versus Efavirenz plus Emtricitabine/Tenofovir
3 A Prospective Randomized Trial Comparing the Response of HIV Kaposi's Sarcoma (KS) to HAART Versus the Combination of HAART and Chemotherapy (CXT) Completed NCT00380770 Phase 4 Generic HAART Triomune : d4T, 3TC, NVP;Generic HAART Triomune : d4T, 3TC, NVP and chemotherapy ABV
4 Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma Completed NCT03514381 Phase 4 Patients starting a treatment with Doxorubicin and Ifosfamide
5 Prospective, Randomized Evaluation of Hyperbaric Oxygen Therapy on Wound Healing Following Management of Soft Tissue Sarcoma With Neo-Adjuvant Radiation and Surgical Resection Recruiting NCT03144206 Phase 4 Hyperbaric oxygen
6 Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib - a Randomized, Controlled Trial Recruiting NCT03735758 Phase 4 pazopanib or guideline conform chemotherapy
7 Registry of Retroperitoneal, Abdominal, Pelvic and Truncal Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet® to Evaluate the Safety and Feasibility Over 5 Years Recruiting NCT04033081 Phase 4
8 Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule Recruiting NCT04223583 Phase 4 Anlotinib Hydrochloride
9 Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction: A Randomized Controlled Trial Recruiting NCT04347122 Phase 4 Tranexamic Acid (TXA)
10 Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma: a Randomized Controlled Trial Recruiting NCT04448873 Phase 4 Sirolimus
11 Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma: a Single Arm Prospective Study Recruiting NCT04056962 Phase 4 Tacrolimus ointment
12 Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma:A Prospective, Randomized Open Trial Recruiting NCT04077515 Phase 4 Sirolimus(0.8mg/m2);Sirolimus(0.7mg/m2)
13 Low Molecular Weight Heparin Versus Aspirin for Venous Thromboembolism Prophylaxis in Orthopaedic Oncology Enrolling by invitation NCT03244020 Phase 4 Aspirin 325mg;Enoxaparin 40Mg/0.4mL Prefilled Syringe
14 Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan (VI) for Patients With Intermediate-Risk Rhabdomyosarcoma (RMS) Unknown status NCT00354835 Phase 3 Irinotecan Hydrochloride;Cyclophosphamide;Vincristine Sulfate
15 Phase III Study of The Role of Barrier Resection in Local Control in Treatment of Extremity Soft Tissue Sarcomas Unknown status NCT02120768 Phase 3
16 Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age Unknown status NCT00346164 Phase 3 doxorubicin hydrochloride;ifosfamide
17 EUROPEAN INTERGROUP COOPERATIVE EWING'S SARCOMA STUDY [EICESS 92] Unknown status NCT00002516 Phase 3 cyclophosphamide;doxorubicin hydrochloride;etoposide;ifosfamide;mesna;vincristine sulfate
18 Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Adriamycin, Bleomycin, and Vincristine (ABV) in the Treatment of Severe AIDS-Related Kaposi's Sarcoma Unknown status NCT00002318 Phase 3 Doxorubicin hydrochloride (liposomal);Bleomycin sulfate;Vincristine sulfate;Doxorubicin hydrochloride
19 A Phase III Randomized Study of Preoperative Radiotherapy Plus Surgery Versus Surgery Alone for Patients With Retroperitoneal Sarcoma (RPS) Unknown status NCT01344018 Phase 3
20 A Registered Randomized, Double-Blind, Placebo-Controlled (2:1), Multi-Centered Clinical Trial of Anlotinib as a Treatment for Soft Tissue Sarcoma Unknown status NCT02449343 Phase 2, Phase 3 Anlotinib;Placebo
21 A Protocol For Nonmetastatic Rhabdomyosarcoma [RMS-2005] Unknown status NCT00379457 Phase 3 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;ifosfamide;topotecan hydrochloride;vincristine sulfate;vinorelbine tartrate
22 Phase III Study About the Effects of the Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas Unknown status NCT00162721 Phase 3 doxorubicin, ifosfamide, cisplatin
23 European Ewing Tumour Working Initiative of National Groups Ewing Tumour Studies 1999 (EURO-E.W.I.N.G.99) Unknown status NCT00020566 Phase 3 busulfan;doxorubicin hydrochloride;etoposide;ifosfamide;melphalan;vincristine sulfate
24 Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas Unknown status NCT00334854 Phase 3 doxorubicin hydrochloride;ifosfamide
25 Randomized Double-Blind Controlled Phase III Trial of Hyperbaric Oxygen Therapy in Patients Suffering Long-Term Adverse Effects of Radiotherapy for Pelvic Cancer (HOT II) Unknown status NCT01087268 Phase 3
26 A Multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator's Choice in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcomas Who Either Relapsed or Were Refractory to Prior Non-Adjuvant Chemotherapy Completed NCT02049905 Phase 3 Aldoxorubicin;Investigator's Choice Treatment (Darcabazine, Pazopanib, Gemcitabine + Docetaxel, Doxorubicin, Ifosfamide)
27 Establishment of an Indication-based Identification and Psychosocial Treatment of Orthopedic Cancer Patients Suffering From Psychosocial Stress Completed NCT01631175 Phase 3
28 Randomized Study of Vincristine, Actinomycin-D, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine, Topotecan and Cyclophosphamide for Patients With Intermediate Risk Rhabdomyosarcoma Completed NCT00003958 Phase 3 vincristine sulfate;cyclophosphamide;topotecan hydrochloride
29 Ph III Random Trial of 120-Min Infusion Gemcitabine v. 90-Min Infusion Gemcitabine + Docetaxel in Unresectable Soft Tissue Sarcoma: A Multi-Disciplinary Trial of the North Amer. Sarcoma Study Group of the Connective Tissue Oncology Society Completed NCT00142571 Phase 3 Gemcitabine;Docetaxel
30 METASTASECTOMY AND CHEMOTHERAPY FOR LUNG METASTASES FROM SOFT TISSUE SARCOMA: A RANDOMIZED PHASE III STUDY (AN INTERGROUP STUDY WITH THE SCANDINAVIAN SARCOMA GROUP) Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
31 Randomised Trial of Post-Operative Radiotherapy Given to Adult Patients With Extremity Soft Tissue Sarcoma [VORTEX] Completed NCT00423618 Phase 3
32 Open Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma Completed NCT00002319 Phase 3 Doxorubicin hydrochloride (liposomal)
33 A Placebo-Controlled Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS-Associated Kaposi's Sarcoma Completed NCT00000994 Phase 3 Zidovudine
34 A Phase III Randomized Placebo Controlled and Double Blinded Study of IM862 for Patients With Muco-Cutaneous AIDS Associated Kaposi's Sarcoma Completed NCT00002445 Phase 3 IM862
35 Phase 3, Open Label, Multi-centre, Randomised Controlled International Study in Ewing Sarcoma Completed NCT00987636 Phase 3 Zoledronic acid;Busulfan;Treosulfan
36 Trial of Chemotherapy Intensification Through Compression in Ewing's Sarcoma and Related Tumors Completed NCT00006734 Phase 3 cyclophosphamide;doxorubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
37 Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma. Completed NCT00002147 Phase 3 Doxorubicin hydrochloride (liposomal)
38 Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma Completed NCT00002105 Phase 3 Doxorubicin hydrochloride (liposomal);Bleomycin sulfate;Vincristine sulfate
39 Phase III Study of Paclitaxel Versus Liposomal Doxorubicin for the Treatment of Advanced AIDS-Associated Kaposi's Sarcoma Completed NCT00003350 Phase 3 paclitaxel;pegylated liposomal doxorubicin hydrochloride
40 Double-Blind Randomized Evaluation of Clinical Benefits of DOXIL in Patients With AIDS-Related Kaposi's Sarcoma Treated With DOXIL or DaunoXome Completed NCT00002985 Phase 3 daunorubicin hydrochloride;pegylated liposomal doxorubicin hydrochloride
41 A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. Completed NCT00002093 Phase 3 Daunorubicin (liposomal);Bleomycin sulfate;Vincristine sulfate;Doxorubicin hydrochloride
42 A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe Completed NCT00834457 Phase 2, Phase 3 abacavir/3TC/zidovudine;abacavir /3TC plus ritonavir boosted lopinavir
43 A Randomized Evaluation of Antiretroviral Therapy Alone or With Delayed Chemotherapy Versus Antiretroviral Therapy With Immediate Adjunctive Chemotherapy for Treatment of Limited Stage AIDS-KS in Resource-Limited Settings (REACT-KS) AMC 067 Completed NCT01352117 Phase 3 efavirenz/emtricitabine/tenofovir disoproxil fumarate;etoposide
44 Randomized Double-blind Placebo-controlled Trial of Primary Prophylaxis With Recombinant Human Thrombopoietin Administered to Patients With High Risk Sarcoma Receiving Intensive Chemotherapy Completed NCT00283582 Phase 3 rhTPO
45 Actinomycin D and Vincristine With or Without Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Rhabdomyosarcoma or Undifferentiated Sarcoma: IRS-V Protocol Completed NCT00002995 Phase 3 cyclophosphamide;vincristine sulfate
46 A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination With Doxorubicin vs. Doxorubicin Alone in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma Completed NCT01440088 Phase 3 TH-302 in Combination with Doxorubicin;Doxorubicin
47 A Phase III Multicenter, International, Randomized, Double-blind, Placebo-controlled Study of Doxorubicin Plus Palifosfamide-tris vs. Doxorubicin Plus Placebo in Patients With Front-line Metastatic Soft Tissue Sarcoma. Completed NCT01168791 Phase 3 doxorubicin in combination with palifosfamide-tris;doxorubicin in combination with placebo
48 Randomized Phase III Trial of Two Investigational Schedules of Ifosfamide vs. Standard Dose Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3 doxorubicin hydrochloride;ifosfamide
49 RANDOMISED TRIAL OF ADJUVANT CHEMOTHERAPY WITH HIGH-DOSE DOXORUBICIN, IFOSFAMIDE AND LENOGRASTIM IN HIGH GRADE SOFT TISSUE SARCOMA Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
50 Phase III Randomized Study of Adjuvant Pelvic Radiotherapy Versus Observation Alone in Patients With Completely Resected, Stage I or II, High-Grade Uterine Sarcoma Completed NCT00002459 Phase 3

Search NIH Clinical Center for Malignant Mesenchymoma

Inferred drug relations via UMLS 70 / NDF-RT 51 :


Ifosfamide
Mitoxantrone
Mitoxantrone Hydrochloride
Thiotepa

Cochrane evidence based reviews: malignant mesenchymal tumor

Genetic Tests for Malignant Mesenchymoma

Anatomical Context for Malignant Mesenchymoma

MalaCards organs/tissues related to Malignant Mesenchymoma:

40
Bone, Uterus, T Cells, Myeloid, Breast, Bone Marrow, Liver

Publications for Malignant Mesenchymoma

Articles related to Malignant Mesenchymoma:

(show top 50) (show all 460)
# Title Authors PMID Year
1
Long-term outcomes after cytoreductive surgery and HIPEC for morcellated uterine leiomyosarcoma; A case series. 61
33748383 2021
2
Undifferentiated embryonal sarcoma of the liver presenting as a hemorrhagic mass in a pregnant woman. 61
33640792 2021
3
Primary Synovial Sarcoma of the Orbit: A Case Report and Update on Diagnostic Techniques. 61
33587418 2021
4
Successful treatment of advanced alveolar soft part sarcoma with camrelizumab combined with apatinib: a case report. 61
33545800 2021
5
Primary intradural/extradural Ewing's sarcoma of the sacral spine: A case report and literature review. 61
33500832 2021
6
[Resection of a Desmoid Tumor Originated from Greater Omentum with No History of Open Surgery]. 61
33468889 2020
7
Endometrial stromal sarcoma extending to the pulmonary artery: A rare case report. 61
33344553 2020
8
Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series, a population-based analysis and review of the literature. 61
33313103 2020
9
A Rare Case of Primary Malignant Mesenchymoma Arising from Submandibular Salivary Gland. 61
33335748 2020
10
Imaging characteristics and prognostic values of hepatic epithelioid hemangioendothelioma on 18F-FDG PET/CT. 61
32797371 2020
11
MiR-429 and MiR-143-3p Function as Diagnostic and Prognostic Markers for Osteosarcoma. 61
33073957 2020
12
Application of Computed Tomography Images Based on Peripheral Nerve Analysis in the Treatment of Gastric Scrotal Tumors. 61
33075572 2020
13
Primary Retrobulbar Leiomyosarcoma in a Dog: A Case Report. 61
32992611 2020
14
Cotyledonoid Leiomyoma Clinical Characteristics, Imaging Features, and Review of the Literature. 61
32955750 2020
15
Radiation-induced angiosarcoma (RIAS) of the maxilla: a case report. 61
32855377 2020
16
Important prognostic factors in leiomyosarcoma survival: a National Cancer Database (NCDB) analysis. 61
31392646 2020
17
Uterine PEComa with aggressive behavior: A review with an additional case of spontaneous vaginal expulsion. 61
32527449 2020
18
Progress in determining response to treatment in gastrointestinal stromal tumor. 61
32191549 2020
19
[The role of interleukin-11 in osteosarcoma]. 61
32078699 2020
20
Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience. 61
31750944 2020
21
Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse Model. 61
31896528 2020
22
Infantile Epithelioid Sarcoma with Genomic Segmental Amplification of BIRC3/YAP1 as Double Minutes Plus Trisomy 2: A Case Report. 61
31215292 2020
23
A case of hepatic leiomyosarcoma with osteosarcomatous differentiation (malignant mesenchymoma) in a dog. 61
32051664 2020
24
MDM2 dual-color in situ hybridization (DISH) aids the diagnosis of intimal sarcomas. 61
31442826 2019
25
Non-epithelial tumors of the larynx: case series of 12 years. 61
31256243 2019
26
Conjunctival Leiomyosarcoma, a Rare Neoplasm Always Originating at the Limbus? Report of a New Case and Review of 11 Published Cases. 61
31559244 2019
27
Cluster of Differentiation 10 Positive Stromal Sarcoma of Breast: A Diagnostic Challenge. 61
31523571 2019
28
Bilateral Anterior Uveitis in a Northern Saw-whet Owl (Aegolius acadicus) With a Metastatic Pectoral Malignant Mesenchymoma. 61
31251505 2019
29
Dermatofibrosarcoma protuberans: surgical management of a challenging mesenchymal tumor. 61
31138233 2019
30
A girl with a giant fibrolipoma in her thoracic cavity: a rare case report. 61
31060610 2019
31
Imaging findings of ovarian leiomyosarcoma with histopathologic correlations. 61
30898403 2019
32
Rare malignant glomus tumor of the stomach with liver metastases. 61
30766648 2019
33
Deep dermal and subcutaneous canine hemangiosarcoma in the perianal area: diagnosis of perianal mass in a dog. 61
30987633 2019
34
Retroperitoneal Liposarcoma Masquerading as an Impending Rupture of Inflammatory Abdominal Aortic Aneurysm. 61
30496898 2019
35
Scapula chondrosarcoma: A case report. 61
31027132 2019
36
Cutaneous leiomyosarcoma: a clinical, dermoscopic, pathologic case study. 61
30932400 2019
37
ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report. 61
30675302 2019
38
Recurrent intrathoracic dedifferentiated liposarcoma: A case report and literature review. 61
30847274 2019
39
Rare Breast Malignancy Subtypes: A Cytological, Histological, and Immunohistochemical Correlation. 61
31007516 2019
40
Lesser Sac Glomangiosarcoma With Simultaneous Liver And Lymph Nodes Metastases Mimicking Small Bowel Gastrointestinal Stromal Tumor; Immunohistochemistry And Empirical Chemotherapy. 61
31814776 2019
41
Laryngeal synovial sarcoma: Report of 2 cases. 61
30482506 2018
42
A Case of Undifferentiated Sarcoma in the Superior Vena Cava and Bilateral Cervical Veins. 61
30563958 2018
43
A giant primary hepatic low-grade malignant mesenchymal tumor of the liver in a teenager. 61
30652103 2018
44
Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution. 61
30007495 2018
45
Clinicopathological features, treatment and survival outcomes of synovial sarcoma. 61
30430100 2018
46
Low-grade endometrial stromal sarcoma presenting as multiple pulmonary nodules: A potential pitfall in fine needle aspiration and core biopsy specimens - A Cytological - Pathological Correlation. 61
30055523 2018
47
Long period of relative quiescence in distal-type epithelioid sarcoma of the forearm with recurrence after surgery: A case report. 61
30200169 2018
48
Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups. 61
29781567 2018
49
Clinical and pathological characteristics of a series of patients with newly diagnosed primary renal liposarcoma: natural history and effect on survival. 61
29991665 2018
50
Metaplastic spindle cell carcinoma of the breast in a patient with neurofibromatosis type 1. 61
29139585 2018

Variations for Malignant Mesenchymoma

Expression for Malignant Mesenchymoma

Search GEO for disease gene expression data for Malignant Mesenchymoma.

Pathways for Malignant Mesenchymoma

Pathways related to Malignant Mesenchymoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.9 MYOG MYOD1 DES CD34

GO Terms for Malignant Mesenchymoma

Biological processes related to Malignant Mesenchymoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 skeletal muscle fiber development GO:0048741 9.46 MYOG MYOD1
2 skeletal muscle tissue regeneration GO:0043403 9.43 MYOG MYOD1
3 muscle organ development GO:0007517 9.43 SMTN MYOG MYOD1
4 positive regulation of myoblast differentiation GO:0045663 9.4 MYOG MYOD1
5 myoblast differentiation GO:0045445 9.37 MYOG MYOD1
6 myotube differentiation GO:0014902 9.32 MYOG MYOD1
7 positive regulation of skeletal muscle fiber development GO:0048743 9.16 MYOG MYOD1
8 muscle cell fate commitment GO:0042693 8.96 MYOG MYOD1
9 positive regulation of muscle cell differentiation GO:0051149 8.8 MYOG MYOD1 MDM2

Sources for Malignant Mesenchymoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....